The Research Progress on Predictive Factors and Adverse Reactions of RAI Treatment in Patients with Moderate and High-Risk DTC

WEN Runze, ZHANG Bin

PDF(1041 KB)
Welcome to Labeled Immunoassays and Clinical Medicine website!
PDF(1041 KB)
Labeled Immunoassays and Clinical Medicine ›› 2022, Vol. 29 ›› Issue (12) : 2147-2153. DOI: 10.11748/bjmy.issn.1006-1703.2022.12.033
Review

The Research Progress on Predictive Factors and Adverse Reactions of RAI Treatment in Patients with Moderate and High-Risk DTC

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 29(12): 2147-2153 https://doi.org/10.11748/bjmy.issn.1006-1703.2022.12.033

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1041 KB)

Accesses

Citation

Detail

Sections
Recommended

/